Myocardial Protection and Anesthetic Agents

• Status: Completed
• Trial end date: 2015-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study was to investigate the myocardial protective effects of remifentanil and dexmedetomidine in cardiac surgery.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cukurova University
• Treatments: Dexmedetomidine; Remifentanil; Sevoflurane

Criteria

Inclusion Criteria:

• Scheduled to open heart surgery

• American Society of Anesthesiologists (ASA) physical status of II-III

Exclusion Criteria:

• Emergency surgery, prior cardiac surgery, ejection fraction < 50%, restrictive or obstructive pulmonary disease, preoperative mechanical ventilation, intra-aortic balloon pump, chronic liver and renal failure.